Antioxidants (Mar 2022)

Deuterated Arachidonic Acid Ameliorates Lipopolysaccharide-Induced Lung Damage in Mice

  • Alla Y. Molchanova,
  • Svetlana N. Rjabceva,
  • Tigran B. Melik-Kasumov,
  • Nikolay B. Pestov,
  • Plamena R. Angelova,
  • Vadim V. Shmanai,
  • Olga L. Sharko,
  • Andrei V. Bekish,
  • Genevieve James,
  • Hui Gyu Park,
  • Irina A. Udalova,
  • J. Thomas Brenna,
  • Mikhail S. Shchepinov

DOI
https://doi.org/10.3390/antiox11040681
Journal volume & issue
Vol. 11, no. 4
p. 681

Abstract

Read online

Arachidonic acid (ARA) is a major component of lipid bilayers as well as the key substrate for the eicosanoid cascades. ARA is readily oxidized, and its non-enzymatic and enzymatic oxidation products induce inflammatory responses in nearly all tissues, including lung tissues. Deuteration at bis-allylic positions substantially decreases the overall rate of ARA oxidation when hydrogen abstraction is an initiating event. To compare the effects of dosing of arachidonic acid (H-ARA) and its bis-allylic hexadeuterated form (D-ARA) on lungs in conventionally healthy mice and in an acute lung injury model, mice were dosed with H-ARA or D-ARA for six weeks through dietary supplementation and then challenged with intranasal lipopolysaccharide (LPS) for subsequent analysis of bronchoalveolar lavage fluid and lung tissue. Dosing on D-ARA resulted in successful incorporation of D-ARA into various tissues. D-ARA significantly reduced LPS-induced adverse effects on alveolar septal thickness and the bronchoalveolar area. Oral deuterated ARA is taken up efficiently and protects against adverse LPS-induced pathology. This suggests novel therapeutic avenues for reducing lung damage during severe infections and other pathological conditions with inflammation in the pulmonary system and other inflammatory diseases.

Keywords